Evidence map›Paper›PMID 40485249›Full record

ArticleJournal of diabetes science and technology2025

Disparities in Time to Technology Initiation in the Year Following Diagnosis of Type 1 Diabetes among Youth: A Retrospective Cohort Study.

Elise Tremblay, Lori Laffel

Abstract read
In one paragraph

Article in Journal of diabetes science and technology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Elise TremblayDivision of Endocrinology, Department of Pediatrics, Boston Children's Hospital, Boston, MA, USA.ORCID 0000-0003-0950-6393
Lori LaffelDivision of Endocrinology, Department of Pediatrics, Boston Children's Hospital, Boston, MA, USA.ORCID 0000-0002-9675-3001

Funding

CAREER DEVELOPMENT IN DIABETES RESEARCH FOR PEDIATRIC ENDOCRINOLOGISTSK12DK094721 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI LAFFEL, LORI M, WHITE, MORRIS F. · 2011 to 2021
$6.3M
Optimizing Use of Continuous Glucose Monitoring (CGM) to Improve Care for Youth with Type 1 Diabetes K23DK133685 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI Elise Schlissel Tremblay · 2023 to 2026
$774k
NIDDK NIH HHS K12 DK094721NIDDK NIH HHS K23 DK133685
6 · The paper itself

Abstract

backgroundDespite rapidly evolving diabetes technology and evidence that early access to technologies improves outcomes, there is disparate use based on socio-demographic factors. We sought to characterize technology uptake in the year following diagnosis of type 1 diabetes in youth based on race/ethnicity, insurance, and household structure.

methodsWe conducted a retrospective cohort study of 692 youth diagnosed with and treated for type 1 diabetes between 2016 and 2020 at a children's hospital. Medical record review provided outcomes of interest, including time to initiation of continuous glucose monitors (CGMs), insulin pump therapy, or both. We used cumulative incidence curves and competing risks regression to compare time to initiation by socio-demographic groups.

resultsThere were 692 youth, 59% male, diagnosed at a mean age of 10.8 (±4.2) years, in the sample. The majority (83.2%) were White, English-speaking (94.4%), and privately insured (76.7%), with 71.7% living in two-parent households. Cumulative incidence curves and competing risks regression showed that publicly insured youth had a lower likelihood of starting diabetes technologies in the year following diagnosis than privately insured youth. Black and Hispanic youth were less likely than white youth to start CGM and insulin pumps. Youth from non-intact households similarly exhibited lower rates of technology uptake. Hazard ratios for time to both technologies were comparable to those for time to insulin pump.

conclusionsThese findings highlight the importance of developing interventions to advance diabetes technology use from onset of type 1 diabetes for all youth.

Indexed as

childhood type 1 diabetesclosed-loop insulin deliverycontinuous glucose monitoringcontinuous subcutaneous insulin infusion (CSII)health equity and disparities

Identifiers

PMID40485249
PMCPMC12149155

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.